Profile data is unavailable for this security.
About the company
Hims & Hers Health, Inc. provides a consumer-first platform, which helps customers to fulfill their health and wellness needs. The Company’s digital platform offers access to a provider network, a clinically focused electronic medical record system, digital prescriptions and cloud pharmacy fulfillment. Its digital platform provides access to treatments for a range of conditions, including those related to sexual health, hair loss, dermatology, mental health and weight loss. The Company connects patients to licensed healthcare professionals who can prescribe medications when appropriate. In addition, the Company also offers access to a range of health and wellness products designed to meet individual needs, which includes curated prescription and non-prescription products. Its Hims & Hers mobile application enables consumers to access a range of educational programs, wellness content, community support and other services that promote lifelong health and wellness.
- Revenue in USD (TTM)959.40m
- Net income in USD-2.35m
- Incorporated2021
- Employees1.05k
- LocationHims & Hers Health Inc2269 Chestnut St, #523SAN FRANCISCO 94123United StatesUSA
- Phone+1 (415) 851-0195
- Fax+1 (302) 655-5049
- Websitehttps://www.forhims.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Guardant Health Inc | 603.73m | -460.90m | 3.32bn | 1.78k | -- | 48.33 | -- | 5.49 | -3.92 | -3.92 | 5.17 | 0.5607 | 0.3754 | 4.37 | 7.03 | 339,362.00 | -28.66 | -22.26 | -33.02 | -24.59 | 60.37 | 64.62 | -76.34 | -97.07 | 5.66 | -59.55 | 0.9435 | -- | 25.45 | 44.14 | 26.76 | -- | 0.2786 | -- |
Ultragenyx Pharmaceutical Inc | 442.59m | -613.35m | 3.34bn | 1.28k | -- | 23.78 | -- | 7.54 | -8.02 | -8.02 | 5.75 | 1.69 | 0.329 | 1.61 | 6.18 | 346,854.20 | -45.59 | -33.35 | -55.09 | -38.30 | 88.59 | 93.13 | -138.58 | -154.71 | 2.28 | -- | 0.00 | -- | 19.52 | 53.18 | 14.25 | -- | 62.91 | -- |
Axsome Therapeutics Inc | 251.02m | -296.38m | 3.49bn | 545.00 | -- | 24.20 | -- | 13.89 | -6.38 | -6.38 | 5.41 | 3.03 | 0.537 | 2.11 | 3.43 | 460,592.70 | -63.40 | -64.55 | -85.88 | -82.23 | 90.12 | -- | -118.07 | -227.05 | 3.09 | -55.54 | 0.556 | -- | 440.80 | -- | -27.84 | -- | 77.86 | -- |
Crinetics Pharmaceuticals Inc | 1.97m | -235.46m | 3.50bn | 290.00 | -- | 3.99 | -- | 1,774.14 | -3.77 | -3.77 | 0.0315 | 11.14 | 0.0031 | -- | 0.3653 | 6,806.90 | -35.57 | -42.53 | -37.86 | -45.36 | -- | -- | -11,641.13 | -5,446.39 | -- | -- | 0.00 | -- | -15.28 | 10.57 | -30.88 | -- | 34.65 | -- |
Merus NV | 38.34m | -149.65m | 3.59bn | 172.00 | -- | 8.94 | -- | 93.56 | -2.72 | -2.72 | 0.7031 | 5.95 | 0.0917 | -- | 1.21 | 222,889.50 | -35.78 | -29.35 | -43.82 | -35.36 | -- | -- | -390.36 | -252.21 | -- | -- | 0.00 | -- | 5.68 | 2.75 | -18.10 | -- | -1.73 | -- |
Immunovant Inc | 0.00 | -259.34m | 3.71bn | 207.00 | -- | 5.98 | -- | -- | -1.89 | -1.89 | 0.00 | 4.24 | 0.00 | -- | -- | 0.00 | -48.37 | -- | -52.91 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -22.93 | -- | -- | -- |
Simply Good Foods Co | 1.27bn | 140.76m | 3.85bn | 271.00 | 27.63 | 2.34 | 23.77 | 3.04 | 1.39 | 1.39 | 12.53 | 16.48 | 0.5977 | 6.91 | 8.56 | 4,671,908.00 | 6.65 | 3.66 | 6.95 | 3.83 | 37.26 | 38.90 | 11.12 | 6.80 | 3.09 | 9.26 | 0.1261 | 0.00 | 6.33 | 23.56 | 23.03 | 13.65 | 47.09 | -- |
Alkermes Plc | 1.73bn | 599.95m | 3.96bn | 2.10k | 6.68 | 3.16 | 5.96 | 2.29 | 3.50 | 2.53 | 10.05 | 7.42 | 0.8532 | 1.32 | 5.81 | 821,991.40 | 29.65 | 1.34 | 38.77 | 1.74 | 85.31 | 83.32 | 34.76 | 2.12 | 2.77 | -- | 0.1878 | 0.00 | 49.61 | 8.74 | 1,665.99 | -- | -7.10 | -- |
Hims & Hers Health Inc | 959.40m | -2.35m | 4.17bn | 1.05k | -- | 12.09 | 518.28 | 4.35 | -0.0145 | -0.0145 | 4.46 | 1.61 | 2.33 | 6.68 | 176.36 | 917,209.40 | -0.5704 | -- | -0.6968 | -- | 82.41 | -- | -0.245 | -- | 2.48 | -- | 0.00 | -- | 65.49 | -- | 64.15 | -- | -- | -- |
Alvotech SA | 114.39m | -494.28m | 4.20bn | 999.00 | -- | -- | -- | 36.73 | -2.05 | -2.05 | 0.4909 | -2.47 | 0.117 | 1.69 | 1.97 | 114,507.50 | -50.54 | -- | -63.82 | -- | -23.89 | -- | -432.09 | -- | 0.8107 | -1.26 | 2.49 | -- | 9.84 | -- | -7.43 | -- | -- | -- |
Nuvalent Inc | 0.00 | -145.51m | 4.24bn | 106.00 | -- | 6.27 | -- | -- | -2.41 | -2.41 | 0.00 | 10.47 | 0.00 | -- | -- | 0.00 | -24.88 | -- | -26.01 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -54.20 | -- | -- | -- |
Immunitybio Inc | 302.00k | -600.96m | 4.44bn | 628.00 | -- | -- | -- | 14,701.54 | -1.05 | -1.05 | 0.0005 | -1.02 | 0.0008 | -- | 0.1677 | 480.89 | -161.65 | -112.76 | -946.50 | -316.07 | -- | -- | -199,138.70 | -37,700.74 | -- | -1.92 | 5.32 | -- | 159.17 | 67.62 | -40.00 | -- | 18.48 | -- |
Krystal Biotech Inc | 95.95m | 57.16m | 4.57bn | 229.00 | 85.04 | 5.71 | 72.06 | 47.64 | 1.88 | 1.88 | 3.38 | 28.02 | 0.1385 | -- | -- | 418,991.30 | 8.25 | -11.50 | 8.78 | -12.01 | 94.25 | -- | 59.57 | -492.85 | 12.42 | -- | 0.00 | -- | -- | -- | 107.81 | -- | 39.49 | -- |
Apellis Pharmaceuticals Inc | 524.07m | -417.27m | 4.76bn | 702.00 | -- | 17.85 | -- | 9.09 | -3.46 | -3.46 | 4.33 | 2.20 | 0.5788 | 0.5747 | 3.50 | 746,538.40 | -46.09 | -73.88 | -57.28 | -90.03 | 86.47 | -- | -79.62 | -326.49 | 3.02 | -39.71 | 0.6087 | -- | 425.83 | -- | 18.94 | -- | -- | -- |
Madrigal Pharmaceuticals Inc | 0.00 | -444.28m | 5.03bn | 376.00 | -- | 5.74 | -- | -- | -23.08 | -23.08 | 0.00 | 41.13 | 0.00 | -- | -- | 0.00 | -62.81 | -62.09 | -73.92 | -74.81 | -- | -- | -- | -- | 9.39 | -- | 0.1201 | -- | -- | -- | -26.50 | -- | 132.01 | -- |
Holder | Shares | % Held |
---|---|---|
The Vanguard Group, Inc.as of 31 Mar 2024 | 13.96m | 6.78% |
BlackRock Fund Advisorsas of 31 Mar 2024 | 9.11m | 4.42% |
Marshall Wace LLPas of 31 Mar 2024 | 5.64m | 2.74% |
SSgA Funds Management, Inc.as of 31 Mar 2024 | 3.05m | 1.48% |
Voloridge Investment Management LLCas of 31 Mar 2024 | 3.05m | 1.48% |
Geode Capital Management LLCas of 31 Mar 2024 | 2.95m | 1.43% |
Renaissance Technologies LLCas of 31 Mar 2024 | 2.83m | 1.38% |
Dimensional Fund Advisors LPas of 31 Mar 2024 | 2.61m | 1.27% |
Merrill Lynch, Pierce, Fenner & Smith, Inc. (Invt Mgmt)as of 31 Mar 2024 | 2.09m | 1.02% |
American Century Investment Management, Inc.as of 31 Mar 2024 | 2.08m | 1.01% |